JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/21.06.24

JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/21.06.24 Share Price

Warrant

DE000JL7JMY6

Market Closed - Börse Stuttgart 07:45:55 23/05/2024 pm IST
0.001 ^EUR	-.--%

3 months	-85.71%
6 months	-66.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/21.06.24

Latest news about EDWARDS LIFESCIENCES CORPORATION

Some of the biggest splits in Corporate America	23/05	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	22/05	MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	14/05	MT

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	J.P. Morgan
WKN	JL7JMY
ISIN	DE000JL7JMY6
Date issued	13/07/2023
Strike	125 $
Maturity	21/06/2024 (20 Days)
Parity	10 : 1
Emission price	0.22 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.23 €
Lowest since issue	0.001 €
Spread	0.05 €
Spread %	98.04%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company